Treatment to protect mitochondria may enter clinical trials this year
An experimental therapy called ASHA-091, which was seen to restore normal mitochondria function and possibly be disease modifying in a mouse model of Parkinson’s disease, may soon be moving into clinical trials, its developer, Asha Therapeutics, reports. Problems with the workings of mitochondria, a cell’s…